AMETEK
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 03:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 8-K | 2026-11-20 | Read on SEC.gov |
| 8-K | 2026-11-18 | Read on SEC.gov |
| 8-K | 2026-11-06 | Read on SEC.gov |
| 10-Q | 2026-11-03 | Read on SEC.gov |
| 8-K | 2026-11-03 | Read on SEC.gov |
| 8-K | 2026-08-26 | Read on SEC.gov |
| 8-K | 2026-08-11 | Read on SEC.gov |
| 10-Q | 2026-08-04 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-21 14:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $7.40B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Net income | $1.48B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Operating cash flow | $1.80B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Total assets | $16.07B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Total liabilities | $5.44B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Stockholders’ equity | $10.63B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Cash and cash equivalents | $457.95M | As of | 2025-12-31 | 2026-02-17 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 7.57, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Electronic Instruments Group (EIG) is the largest reported line at 64.96% of revenue, across 2 reported segments.
- Electromechanical (EMG) follows at 35.04%, so the top line still matters most but isn’t the whole story.
Revenue annual, last 8 years
Latest year +6.63% YoY
Margins
- Gross margin
- 36.04%
- Operating margin
- 25.81%
- Net margin
- 20.00%
Key ratios & quality
- Enterprise valuei
- 53.00B
- PEG ratioi
- 3.71
- Altman Z-Scorei
- 7.57
PEG uses trailing P/E against the 3-year net income growth rate (8.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.85B | 5.16B | 4.54B | 5.55B | 6.15B | 6.60B | 6.94B | 7.40B |
| Gross profit | 1.66B | 1.79B | 1.54B | 1.91B | 2.15B | 2.38B | 2.48B | 2.67B |
| Selling & admin expenses | 584.02M | 610.28M | 515.63M | 603.94M | 644.58M | 677.01M | 696.91M | 757.12M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.08B | 1.18B | 1.03B | 1.31B | 1.50B | 1.71B | 1.78B | 1.91B |
| Pretax profit | 987.75M | 1.07B | 1.08B | 1.22B | 1.43B | 1.61B | 1.66B | 1.80B |
| Tax | 209.81M | 208.45M | 209.87M | 233.12M | 269.15M | 293.22M | 285.42M | 318.20M |
| Net profit | 777.93M | 861.30M | 872.44M | 990.05M | 1.16B | 1.31B | 1.38B | 1.48B |
| Basic EPS | 3 | 4 | 4 | 4 | 5 | 6 | 6 | 6 |
| Diluted EPS | 3.34 | 3.75 | 3.77 | 4.25 | 5.01 | 5.67 | 5.93 | 6.40 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 1.78B | 1.89B | 2.00B | 1.93B | 2.04B | 2.22B |
| Gross profit | 635.89M | 686.14M | 720.41M | 717.56M | 735.04M | 810.43M |
| Selling & admin expenses | 174.26M | 197.76M | 214.93M | 202.62M | 206.85M | 225.49M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 461.63M | 488.38M | 505.48M | 514.94M | 528.19M | 584.95M |
| Pretax profit | 442.17M | 447.97M | 473.98M | 492.98M | 492.37M | 521.92M |
| Tax | 83.80M | 76.55M | 75.38M | 93.62M | 85.48M | 95.62M |
| Net profit | 358.37M | 371.42M | 398.60M | 399.36M | 406.90M | 426.30M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.55 | 1.60 | 1.73 | 1.74 | 1.77 | 1.85 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.84B | 2.03B | 2.52B | 2.13B | 2.53B | 2.82B | 2.60B | 3.02B |
| Cash & ST investments | 353.98M | 393.03M | 1.21B | 346.77M | 345.39M | 409.80M | 374.00M | 457.95M |
| Inventory | 624.74M | 624.57M | 559.17M | 769.18M | 1.04B | 1.13B | 1.02B | 1.11B |
| Total assets | 8.66B | 9.84B | 10.36B | 11.90B | 12.43B | 15.02B | 14.63B | 16.07B |
| Total current liabilities | 1.26B | 1.43B | 1.08B | 1.56B | 1.56B | 2.88B | 2.10B | 2.84B |
| Short-term debt | 358.88M | 540.47M | 177.23M | 362.45M | 272.45M | 1.48B | 709.08M | 1.27B |
| Long-term debt | 2.27B | 2.27B | 2.28B | 2.23B | 2.16B | 1.90B | 1.43B | 1.07B |
| Total liabilities | 4,420,366,000.00 | 4,729,067,000.00 | 4,408,137,000.00 | 5,026,303,000.00 | 4,954,608,000.00 | 6,293,342,000.00 | 4,975,865,000.00 | 5,438,757,000.00 |
| Total equity | 4.24B | 5.12B | 5.95B | 6.87B | 7.48B | 8.73B | 9.66B | 10.63B |
| Retained earnings | 5.65B | 6.39B | 7.09B | 7.90B | 8.86B | 9.94B | 11.06B | 12.25B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 3.05B | 3.06B | 3.02B | 3.14B | 3.23B | 3.78B |
| Cash & ST investments | 619.71M | 439.24M | 457.95M | 481.25M | 495.45M | 666.15M |
| Inventory | 1.11B | 1.15B | 1.11B | 1.14B | 1.20B | 1.37B |
| Total assets | 15.27B | 16.18B | 16.07B | 16.31B | 16.59B | 22.39B |
| Total current liabilities | 1.87B | 2.65B | 2.84B | 2.76B | 2.66B | 2.64B |
| Short-term debt | 407.65M | 1.04B | 1.27B | 1.11B | 980.63M | 639.82M |
| Long-term debt | 1.53B | 1.43B | 1.07B | 1.06B | 1.06B | 6.03B |
| Total liabilities | 4,877,874,000.00 | 5,655,381,000.00 | 5,438,757,000.00 | 5,390,238,000.00 | 5,333,950,000.00 | 10,692,327,000.00 |
| Total equity | 10.39B | 10.53B | 10.63B | 10.92B | 11.26B | 11.70B |
| Retained earnings | 11.62B | 11.92B | 12.25B | 12.57B | 12.90B | 13.25B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 925.52M | 1.11B | 1.28B | 1.16B | 1.15B | 1.74B | 1.83B | 1.80B |
| Depreciation & amortization | 199.49M | 234.04M | 255.28M | 292.11M | 319.43M | 337.64M | 382.93M | 422.80M |
| Free cash flow | 843.44M | 1.01B | 1.21B | 1.05B | 1.01B | 1.60B | 1.70B | 1.67B |
| Dividends paid | -128.91M | -127.50M | -165.04M | -184.60M | -202.17M | -230.33M | -258.78M | -285.35M |
| Stock buybacks / issuance | -367.68M | -11.92M | -4.69M | -14.71M | -332.82M | -7.77M | -212.03M | -434.05M |
| Ending cash balance | 353.98M | 393.03M | 1.21B | 346.77M | 345.39M | 409.80M | 374.00M | 457.95M |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 359.09M | 440.87M | 584.26M | 451.52M | 483.69M | 560.65M |
| Depreciation & amortization | 107.70M | 103.08M | 105.66M | 105.49M | 105.93M | 115.63M |
| Free cash flow | 329.82M | 419.95M | 527.27M | 426.05M | 451.68M | 527.40M |
| Dividends paid | -71.51M | -71.41M | -70.98M | -77.80M | -77.86M | -77.88M |
| Stock buybacks / issuance | -111.00K | -145.50M | -270.43M | -27.94M | -165.00K | -146.00K |
| Ending cash balance | 619.71M | 439.24M | 457.95M | 481.25M | 495.45M | 666.15M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.81 | 18.41 | 15.77 | 15.44 | 16.16 | 16.21 | 14.97 | 14.59 |
| ROA %i | 9.45 | 9.31 | 8.64 | 8.90 | 9.53 | 9.57 | 9.28 | 9.64 |
| ROIC %i | 12.89 | 12.60 | 11.53 | 11.81 | 12.59 | 12.47 | 12.30 | 12.49 |
| 5-year avg ROE %i | 17.96 | 17.97 | 17.49 | 17.43 | 16.92 | 16.40 | 15.71 | 15.48 |
| EBIT margin %i | 22.08 | 22.45 | 25.73 | 23.50 | 24.58 | 25.59 | 25.56 | 25.40 |
| FCF / sales %i | 17.41 | 19.62 | 26.58 | 18.93 | 16.43 | 24.24 | 24.52 | 22.58 |
| Current ratioi | 1.46 | 1.42 | 2.34 | 1.36 | 1.62 | 0.98 | 1.24 | 1.06 |
| Quick ratioi | 0.86 | 0.80 | 1.68 | 0.75 | 0.81 | 0.49 | 0.63 | 0.55 |
| Debt / assetsi | 30.39 | 28.56 | 23.74 | 22.87 | 19.56 | 22.46 | 14.59 | 14.59 |
| LT debt / equityi | 53.60 | 44.40 | 38.35 | 34.32 | 28.88 | 21.71 | 14.76 | 10.11 |
| Interest coveragei | 13.02 | 13.09 | 13.58 | 16.22 | 18.17 | 20.64 | 15.71 | 23.13 |
| Revenue CAGR (3Y) %i | 6.83 | 10.34 | 1.83 | 4.60 | 6.04 | 13.26 | 7.76 | 6.36 |
| Net income CAGR (3Y) %i | 9.60 | 18.92 | 8.58 | 8.37 | 10.42 | 14.60 | 11.60 | 8.48 |
| FCF CAGR (3Y) %i | 11.81 | 13.43 | 16.76 | 7.57 | -0.06 | 9.84 | 17.47 | 18.27 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 14.64 | 14.63 | 14.59 | 14.63 | 14.56 | 14.68 |
| ROA %i | 9.56 | 9.49 | 9.64 | 9.80 | 9.89 | 8.46 |
| ROIC %i | 12.43 | 12.34 | 12.49 | 12.77 | 12.92 | 11.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 26.11 | 25.81 | 25.40 | 25.54 | 25.48 | 25.57 |
| FCF / sales %i | 24.12 | 22.93 | 22.58 | 22.42 | 23.21 | 23.59 |
| Current ratioi | 1.63 | 1.16 | 1.06 | 1.14 | 1.21 | 1.43 |
| Quick ratioi | 0.88 | 0.59 | 0.55 | 0.59 | 0.63 | 0.76 |
| Debt / assetsi | 12.72 | 15.23 | 14.59 | 13.35 | 12.27 | 29.79 |
| LT debt / equityi | 14.77 | 13.55 | 10.11 | 9.73 | 9.37 | 51.55 |
| Interest coveragei | 21.97 | 23.01 | 23.13 | 23.33 | 20.78 | 18.42 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 20:02:27 · For reference only, not investment advice and not tailored to your situation.
AMETEK discussion 0 comments